10544-1-AP
antibody from Proteintech Group
Targeting: TAF9
AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10544-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10544-1-AP, RRID:AB_2271416
- Product name
- TAF9 antibody
- Antibody type
- Polyclonal
- Description
- TAF9 antibody (Cat. #10544-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Stable Isotope Tracing Uncovers Reduced γ/β-ATP Turnover and Metabolic Flux Through Mitochondrial-Linked Phosphotransfer Circuits in Aggressive Breast Cancer Cells.
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models.
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.
Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.
Klepinin A, Miller S, Reile I, Puurand M, Rebane-Klemm E, Klepinina L, Vija H, Zhang S, Terzic A, Dzeja P, Kaambre T
Frontiers in oncology 2022;12:892195
Frontiers in oncology 2022;12:892195
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models.
Shin HY, Lee EJ, Yang W, Kim HS, Chung D, Cho H, Kim JH
Cancers 2022 Feb 6;14(3)
Cancers 2022 Feb 6;14(3)
Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.
Wang R, Wang Z, Sun R, Fu R, Sun Y, Zhu M, Geng Y, Gao D, Tian X, Zhao Y, Yao J
Frontiers in pharmacology 2021;12:775528
Frontiers in pharmacology 2021;12:775528
Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.
Miao W, Bade D, Wang Y
Journal of proteome research 2021 May 7;20(5):2830-2838
Journal of proteome research 2021 May 7;20(5):2830-2838
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TAF9 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TAF9. This antibody recognizes human,mouse,rat antigen. The TAF9 antibody has been validated for the following applications: ELISA, WB analysis.